C. Guillen et al., The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis, ARTH RHEUM, 43(9), 2000, pp. 2073-2080
Objective. To determine whether lactoferrin can modify articular inflammati
on in murine models of autoimmune and septic arthritis.
Methods. Collagen arthritis was induced in DBA/1 mice and Staphylococcus au
reus septic arthritis in Swiss mice. Joints with established inflammation w
ere injected periarticularly with 0.5 mg or 1 mg of human lactoferrin, and
arthritis was monitored for 3 days.
Results. DBA/1 mice injected with lactoferrin showed significantly suppress
ed local inflammation for up to 3 days, achieving up to 71% of the effect o
f corticosteroid, Periarticular injection of I-125-lactoferrin confirmed th
at 25% of lactoferrin was retained in paws after 6 hours. Serum levels of i
nterleukin-6, however, were not significantly reduced, suggesting a predomi
nantly local antiinflammatory effect. Similarly, local, periarticular admin
istration of lactoferrin into S aureus-infected Swiss mice significantly su
ppressed paw inflammation and did not enhance bacterial survival.
Conclusion. Lactoferrin may have clinical utility in reducing articular inf
lammation, particularly in septic arthritis, in which antiinflammatory effe
cts may be achieved without promoting bacterial survival.